Anxiety-related behaviour of low brain angiotensinogen transgenic rats in the canopy test

Pharmacology, Biochemistry, and Behavior
J-P VoigtA Rex

Abstract

This study investigated risk assessment and anxiolytic/anxiogenic drug effects in "low brain angiotensinogen" transgenic rats (TGR) in comparison to wild-type Sprague-Dawley rats (SD) in the canopy test of anxiety-related behaviour. TGR showed a higher frequency of the risk assessment behaviour as indicated by performance of stretched attend posture (SAP) compared to SD. Diazepam (0.25mg/kg) reduced SAP in both strains, whereas FG-7142 had no significant effect. The 5-HT(1B/2C) agonist mCPP (0.5-2mg/kg) reduced SAP in both strains. Diazepam (0.25-1mg/kg) increased head dips and decreased the time spent under the canopy in SD rats. There were significant anxiogenic effects of both FG-7142 (3-6 mg/kg) and mCPP (0.5-2mg/kg) on these parameters for SD but not TGR. Diazepam (1mg/kg) increased the number of entries into the open zone in both strains. mCPP reduced this parameter in SD (2mg/kg) and TGR (0.5-2mg/kg). FG-7142 had a similar effect in SD (3-6 mg/kg) and TGR (6 mg/kg). This study showed a significant transgenic effect on SAP. The increased number of SAP seen in TGR could be reduced with diazepam. Although both FG-7142 and mCPP are generally anxiogenic, no significant effects of FG-7142 on SAP were observed and mCPP even red...Continue Reading

References

Jan 1, 1988·Annual Review of Psychology·D C Blanchard, R J Blanchard
Sep 1, 1987·Brain Research Bulletin·S E File, H A Baldwin
Feb 1, 1983·British Journal of Clinical Pharmacology·N DesaiD B Barnett
May 1, 1983·Pharmacology, Biochemistry, and Behavior·S J Cooper
May 1, 1996·Pharmacology, Biochemistry, and Behavior·A RexH Fink
Feb 1, 1997·Neuropeptides·I BelchevaC Hadjiivanova
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·M SchinkeM Bader
Jul 28, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J P VoigtH Fink
Mar 21, 2002·Journal of Neurochemistry·Ovidiu BaltatuJosé Cipolla-Neto
Jul 9, 2004·Annals of the New York Academy of Sciences·J M SaavedraJ Zhou
May 5, 2005·Brain Research·Jörg-Peter VoigtHeidrun Fink
Aug 3, 2005·Cellular and Molecular Neurobiology·Juan M Saavedra
Sep 2, 2005·Developmental Psychobiology·Jeremy Ray, Stefan Hansen
Oct 8, 2009·The Journal of Endocrinology·Helge MüllerWalter Raasch

❮ Previous
Next ❯

Citations

Jan 19, 2016·CNS Neuroscience & Therapeutics·Michael OgierLaurent Bezin
Dec 17, 2014·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Anjana BaliAmteshwar Singh Jaggi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.